Medical Marijuana Inc. Announces Update On Management Team and Board of Directors New Advisory Board and Committees To Commence In September
SAN DIEGO, CA–(Business Wire – Sept 8, 2011) – Medical Marijuana Inc (OTC: MJNA) is pleased to announce that it has finished the transition and integration of new management. The company has added several new key members to its management and directors teams. The company has added the following officers and directors effective immediately:
President- Charles J. Larsen
Mr. Larsen has more than 30 years of experience working in government, public, private and start-up companies as an executive manager, including the United States Coast Guard, Associated Consulting, Peskin Associates, Integrated Decision Systems, Tower Asset Management, Financial Management Advisors, Polaris Technology, and Blues Productions. He has significant experience in high volume securities trading; corporate and public debt, equities, options and futures, as well as being an experienced portfolio manager and securities analyst.
Mr. Larsen has been involved at the highest levels of strategic planning, mergers and acquisitions, financial and operational restructuring, public and private corporate finance, governance and compliance. He has proven track record of success at every level of business management. Charles was the first president of Medical Marijuana Inc., he successfully took the company to launch, and after a short time on other ventures he returns to lead the company from a transitional period to a period of high growth, development and acquisition.
Chief Financial Officer- Rob Plomgren
Mr. Plomgren has been a leader in the financial services arena since 1982. He is a managing partner of Cost Segregation Services Inc. of California, a premier cost segregation firm. Previously, Rob was Managing Director of Galen Capital Group, LLC, a health care merchant bank, from 2002 through 2004.
Rob served as a Managing Director of Venture Banking with ColumbusNewport. His primary role was co-managing the origination, structure and placement of the firm’s equity transactions. Previously, Rob spent 16 years in the investment and securities industry, where he developed an expertise in the formation and marketing of private placements and public offerings for middle market companies. He co-managed placements in excess of $800 million in such diverse industries as mortgage servicing, cable television, environmental services, medical technologies and manufacturing. He attained his CFP designation in 1986 and has held series 24 and 7 securities licenses. Rob received his BA and MS from the University of Redlands.
Board of Directors
Chairman- Michelle Sides, Esq
Director- Ted Caligiuri
Director- Gideon Wolf
Director- David Farrand
Risk Management Committee
Gideon Wolff David Farrand
“The Company has performed an exhaustive search to find the above individuals that will lead the Company in new and innovative directions based on a foundation of professionalism and successful accomplishments. We look forward to what each of these individuals will bring to the Company and its future”. Michelle Sides, Chairman.
ABOUT MEDICAL MARIJUANA INC (OTC: MJNA)
Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.
Medical Marijuana Inc.
2665 Ariane Drive Suite 207
San Diego, CA 92117